Drug intelligence / Profile preview

Shuangshen Yigan Dripping Pills

Development stage
Unknown
Lead developer
Heilongjiang Sunflower Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Shuangshen Yigan Dripping Pills is a Traditional Chinese Medicine (TCM) formulation developed by Heilongjiang Sunflower Pharmaceutical Co., Ltd. specifically for the treatment of chronic hepatitis B. The preparation is primarily composed of extracts from *Salvia miltiorrhiza* (Danshen) and *Sophora flavescens* (Kushen). It is designed to clear heat, detoxify the liver, and promote blood circulation to resolve stasis. Pharmacologically, the drug works by reducing serum transaminase levels (ALT and AST), inhibiting the replication of hepatitis B virus (HBV) DNA, and exerting anti-fibrotic effects on liver tissue. The dripping pill dosage form is utilized to enhance the solubility and bioavailability of the herbal active ingredients, such as matrine and tanshinones, allowing for a more rapid therapeutic onset compared to traditional pill formats.

Brand names
Shuangshen Yigan Dripping Pills
Other names
Shuangshen Yigan DiwanShuang Shen Yi Gan Di Wan
02

Targets

TGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on Shuangshen Yigan Dripping Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shuangshen Yigan Dripping Pills.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call